Plexium
Drug DiscoveryWebsite
Developer of protein-degrading therapeutics designed to treat cancer and other serious diseases. The company identifies novel small molecules that redirect ligases to targets of interest or induce deg...
Valuation
$200M
Market implied
Share Price
N/A
Total Raised
$225.1M
Last Round
Later Stage VC (Series B)
Feb 2022
Latest Funding Round
Later Stage VC (Series B)
Feb 28, 2022
$102M
raised
Investors
+18 other investors